{"title":"Buffalo casein derived peptide can alleviates H2O2 induced cellular damage and necrosis in fibroblast cells","authors":"Savita Devi, Naveen Kumar, Suman Kapila, Sanusi Bello Mada, Srinu Reddi, Rishika Vij, Rajeev Kapila","doi":"10.1016/j.etp.2017.04.009","DOIUrl":null,"url":null,"abstract":"<div><p><span>Oxidative stress<span> is one of a critical pathogenic factor in the progression of aging and chronic diseases such as cancer, myocardial inflammation<span> and diabetes. In the present scenario, peptides with short half life and more biological specificities are gaining much attention as prodrugs<span>. Thus, the present investigation carried out to screen potential antioxidative peptide, VLPVPQK to cope with the cellular oxidative damage. Our results showed that treatment of rat fibroblast cells with 0.2</span></span></span></span> <!-->mM H<sub>2</sub>O<sub>2</sub> for 6<!--> <span><span><span>h significantly declined different oxidative stress biomarkers such as SOD, </span>CAT<span>, GSH, and promoted LDH activity. In addition, </span></span>ROS and TNF-α levels were also increased upon H</span><sub>2</sub>O<sub>2</sub> exposure for 6<!--> <span><span>h and thereby, it induced cell death. Amazingly, </span>pretreatment of the peptide (VLPVPQK) significantly elevated cell survivability, by reversing all H</span><sub>2</sub>O<sub>2</sub><span> induced alterations in fibroblast cells. Therefore, our results indicated that, the peptide (VLPVPQK) acted as a potential cytoprotective agent<span>, who restored redox balance and cell homeostasis in cultured fibroblast cells, even after H</span></span><sub>2</sub>O<sub>2</sub> exposure, suggesting that the peptide can be valuable as an effective remedy in treatment of oxidative stress related diseases and skin inflammation related disorders.</p></div>","PeriodicalId":50465,"journal":{"name":"Experimental and Toxicologic Pathology","volume":"69 7","pages":"Pages 485-495"},"PeriodicalIF":0.0000,"publicationDate":"2017-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.etp.2017.04.009","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and Toxicologic Pathology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0940299316303396","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 17
Abstract
Oxidative stress is one of a critical pathogenic factor in the progression of aging and chronic diseases such as cancer, myocardial inflammation and diabetes. In the present scenario, peptides with short half life and more biological specificities are gaining much attention as prodrugs. Thus, the present investigation carried out to screen potential antioxidative peptide, VLPVPQK to cope with the cellular oxidative damage. Our results showed that treatment of rat fibroblast cells with 0.2 mM H2O2 for 6 h significantly declined different oxidative stress biomarkers such as SOD, CAT, GSH, and promoted LDH activity. In addition, ROS and TNF-α levels were also increased upon H2O2 exposure for 6 h and thereby, it induced cell death. Amazingly, pretreatment of the peptide (VLPVPQK) significantly elevated cell survivability, by reversing all H2O2 induced alterations in fibroblast cells. Therefore, our results indicated that, the peptide (VLPVPQK) acted as a potential cytoprotective agent, who restored redox balance and cell homeostasis in cultured fibroblast cells, even after H2O2 exposure, suggesting that the peptide can be valuable as an effective remedy in treatment of oxidative stress related diseases and skin inflammation related disorders.
期刊介绍:
Cessation. The international multidisciplinary journal is devoted to the publication of studies covering the whole range of experimental research on disease processes and toxicology including cell biological investigations. Its aim is to support progress in the interdisciplinary cooperation of researchers working in pathobiology, toxicology, and cell biology independent of the methods applied. During the past decades increasing attention has been paid to the importance of toxic influence in the pathogenesis of human and animal diseases. This is why Experimental and Toxicologic Pathology meets the urgent need for an interdisciplinary journal felt by a wide variety of experts in medicine and biology, including pathologists, toxicologists, biologists, physicians, veterinary surgeons, pharmacists, and pharmacologists working in academic, industrial or clinical institutions.